Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie S Hulshoff

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|April 3, 2023
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?Suzanne I Anjie, Melanie S Hulshoff, Geert D'Haens
Expert Review of Clinical Immunology|April 28, 2022
Emerging therapies for ulcerative colitisJurij Hanzel, Melanie S Hulshoff, Joep Grootjans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Epigenetic Regulation of Endothelial-to-Mesenchymal Transition in Chronic Heart DiseaseMelanie S Hulshoff, Xingbo Xu, Guido Krenning, et al.
Cardiovascular Research|September 11, 2019
Non-coding RNA in endothelial-to-mesenchymal transitionMelanie S Hulshoff, Gonzalo Del Monte-Nieto, Jason Kovacic, et al.
International Journal of Molecular Sciences|April 30, 2020
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo ApplicationsXingbo Xu, Melanie S Hulshoff, Xiaoying Tan, et al.
Seminars in Nephrology|November 11, 2018
Causal Connections From Chronic Kidney Disease to Cardiac FibrosisMelanie S Hulshoff, Sandip K Rath, Xingbo Xu, et al.
FEBS Letters|March 26, 2016
Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cellsXingbo Xu, Xiaoying Tan, Melanie S Hulshoff, et al.
Theranostics|April 1, 2020
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1Tim Wilhelmi, Xingbo Xu, Xiaoying Tan, et al.
Clinical Epigenetics|August 27, 2024
Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair responseSandip Kumar Rath, Gunsmaa Nyamsuren, Björn Tampe, et al.
Nature Communications|August 31, 2018
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosisXingbo Xu, Xiaoying Tan, Björn Tampe, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|April 3, 2023
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?Suzanne I Anjie, Melanie S Hulshoff, Geert D'Haens
Expert Review of Clinical Immunology|April 28, 2022
Emerging therapies for ulcerative colitisJurij Hanzel, Melanie S Hulshoff, Joep Grootjans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Epigenetic Regulation of Endothelial-to-Mesenchymal Transition in Chronic Heart DiseaseMelanie S Hulshoff, Xingbo Xu, Guido Krenning, et al.
Cardiovascular Research|September 11, 2019
Non-coding RNA in endothelial-to-mesenchymal transitionMelanie S Hulshoff, Gonzalo Del Monte-Nieto, Jason Kovacic, et al.
International Journal of Molecular Sciences|April 30, 2020
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo ApplicationsXingbo Xu, Melanie S Hulshoff, Xiaoying Tan, et al.
Seminars in Nephrology|November 11, 2018
Causal Connections From Chronic Kidney Disease to Cardiac FibrosisMelanie S Hulshoff, Sandip K Rath, Xingbo Xu, et al.
FEBS Letters|March 26, 2016
Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cellsXingbo Xu, Xiaoying Tan, Melanie S Hulshoff, et al.
Theranostics|April 1, 2020
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1Tim Wilhelmi, Xingbo Xu, Xiaoying Tan, et al.
Clinical Epigenetics|August 27, 2024
Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair responseSandip Kumar Rath, Gunsmaa Nyamsuren, Björn Tampe, et al.
Nature Communications|August 31, 2018
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosisXingbo Xu, Xiaoying Tan, Björn Tampe, et al.
Pageof 2